Moreover, constitutive activation of Nrf2 in HLRCC is caused by loss of function mutation in CUL3 and gain of function mutations in Nrf2 [61]. The gene discussed is NFE2L2; the disease is hereditary leiomyomatosis and renal cell cancer.